Azitra is trading 6.18% up at $0.19 after-hours on September 14, 2026, versus the regular-session close, with no confirmed company-specific announcement directly explaining the move.

  • Azitra began its H.C. Wainwright conference presentation window on September 14, covering ATR-COSF data and ATR-04 clinical enrollment; available coverage does not explicitly link the event to the increase.
  • Broader markets declined, making macro sentiment unlikely; the move may reflect thin extended-hours liquidity or a delayed conference reaction.